The North America embolic protection devices market is estimated to grow at a significant CAGR of 8.3% during the forecast period. North America has the highest share among all regions and is likely to witness the highest absolute growth during the forecast period. The growth in the region is mainly attributed to the increasing incidence of cardiac diseases such as heart valve disease and CVDs, the surge in the volume of surgeries for treating such diseases, the availability of advanced healthcare infrastructure and constant technological innovations, and the growing acceptance for transcatheter and other minimally invasive procedures. A strong preference for minimally invasive procedures is one of the key reasons for the region’s dominance. As per NCBI (National Center for Biotechnology Information), since 2006, the rate of open-heart surgeries/bypass surgeries has decreased by 38?40%, whereas the rate of endovascular procedures has increased by multiple times for treating various cardiovascular disorders.

The North America embolic protection devices market is segmented based on product, application, and end-user. Based on product, the market is segmented into filter devices and occlusion devices. Based on application, the market is categorized into cardiovascular & peripheral and neurovascular. Based on end-user, the market is fragmented into ambulatory surgery centers, freestanding CATH labs, hospitals, and specialty cardiac centers. 

On the basis of geography, the North America embolic protection devices market is scrutinized into the US and Canada. The US Is leading the market in terms of both value share and growth rate, although, Canada is also projected to record substantial growth rate during the forecast period. The high demand for advanced medical technologies, the increasing public and private healthcare expenditure, the rising geriatric population, and the growing incidence of heart ailments in Canada are major factors driving the market growth. The prevalence of heart valve disease is growing and is estimated in the range of 2?3% in Canada. The prevalence of moderate or severe AS is about 2% and 8% in patients above 75 years and 85 years of age, respectively. AS is the most common heart valve disease in Canada among the elderly population, and more than 100,000 people over 65 years of age in Canada have this disorder. As a result, the demand for advanced replacement procedures such as TAVR is growing at a significant rate since its introduction in the early 2000s.

Lastly, vendors in the region are focusing on developing innovative and advanced products that will offer improved results using embolic protection devices. Cardiac surgeons are adopting less invasive procedures for the removal of peri-procedural debris to reduce the risk of stroke. Therefore, the safety and effectiveness of embolic protection devices to reduce the complications during transcatheter and other minimally invasive heart procedures are influencing the growth of the embolic protection devices market in North America.

Research Methodology

The market study of the North America embolic protection devices market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. North America Embolic Protection Devices Market Research and Analysis by Product
2. North America Embolic Protection Devices Market Research and Analysis by Application
3. North America Embolic Protection Devices Market Research and Analysis by End-user

The Report Covers

• Comprehensive research methodology of the North America embolic protection devices market.
• This report also includes a detailed and extensive market overview with the key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the North America embolic protection devices market.
• Insights about market determinants which are stimulating the North America embolic protection devices market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.